Cargando…

Terson Syndrome – Clinical Presentation, Management, and Visual Outcomes in a Tertiary Centre

PURPOSE: The purpose of this study was to characterize the clinical presentation, management strategy and visual outcomes of patients diagnosed with Terson syndrome and followed in a tertiary centre in Portugal. PATIENTS AND METHODS: A single-centre retrospective study was performed, based on the su...

Descripción completa

Detalles Bibliográficos
Autores principales: Lima-Fontes, Mario, Leuzinger-Dias, Mariana, Rodrigues, Rita, Barros-Pereira, Ricardo, Falcão, Manuel, Fernandes, Vítor, Alves-Faria, Pedro, Falcão-Reis, Fernando, Rocha-Sousa, Amândio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884450/
https://www.ncbi.nlm.nih.gov/pubmed/36721665
http://dx.doi.org/10.2147/OPTH.S396781
_version_ 1784879721069150208
author Lima-Fontes, Mario
Leuzinger-Dias, Mariana
Rodrigues, Rita
Barros-Pereira, Ricardo
Falcão, Manuel
Fernandes, Vítor
Alves-Faria, Pedro
Falcão-Reis, Fernando
Rocha-Sousa, Amândio
author_facet Lima-Fontes, Mario
Leuzinger-Dias, Mariana
Rodrigues, Rita
Barros-Pereira, Ricardo
Falcão, Manuel
Fernandes, Vítor
Alves-Faria, Pedro
Falcão-Reis, Fernando
Rocha-Sousa, Amândio
author_sort Lima-Fontes, Mario
collection PubMed
description PURPOSE: The purpose of this study was to characterize the clinical presentation, management strategy and visual outcomes of patients diagnosed with Terson syndrome and followed in a tertiary centre in Portugal. PATIENTS AND METHODS: A single-centre retrospective study was performed, based on the survey review of the medical records of every consecutive patient diagnosed with Terson syndrome and followed from January 2018 to August 2021. The change in best-corrected visual acuity (BCVA) from baseline to the final evaluation was the primary outcome. RESULTS: Fifteen eyes from 8 patients (50% female) were included. The mean age at diagnosis was 55±7 years. The neurological event was traumatic brain injury in 37.5% (n=3) and subarachnoid haemorrhage in 62.5% of the patients (n=5). Bilateral intraocular haemorrhage occurred in 875% (n=7) of the patients. Vitreous and preretinal haemorrhages occurred each in 66.7% (n=10), intraretinal in 30% (n=3) and subretinal in 13.3% (n=2) of the eyes. In 40% of the eyes (n=6), spontaneous resolution of intraocular haemorrhage occurred, while PPV was performed in the remaining 60% (n=9). Ocular haemorrhage detection occurred 58.47 ± 40.94 days after the neurological event (range 11 to 121 days). Baseline BCVA was 1.11 ± 1.01 logMAR and improved to 0.32 ± 0.69 logMAR in the follow-up period (p=0.004). A positive correlation was found between initial and final BCVA (Spearman’s rho = 0.643, p=0.01). Baseline BCVA of eyes undergoing PPV was lower than of those conservatively managed (1.84±0.72 vs 0.20±0.28 logMAR, p<0.001). However, there were no statistically significant differences in final BCVA after surgery or observation (0.56 ± 0.90 vs 0.04 ± 0.04 logMAR, p=0.149). Longer periods between the neurological and the ophthalmological diagnosis were correlated with worse final BCVA (Spearman’s rho = 0.688, p=0.005). CONCLUSION: Terson syndrome is a potential cause of irreversible visual loss. Diagnosis delay may affect visual prognosis. PPV is indicated when intraocular haemorrhage is dense and does not resolve spontaneously or when visual acuity at presentation is low, allowing for good visual outcomes with minimal complications.
format Online
Article
Text
id pubmed-9884450
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-98844502023-01-30 Terson Syndrome – Clinical Presentation, Management, and Visual Outcomes in a Tertiary Centre Lima-Fontes, Mario Leuzinger-Dias, Mariana Rodrigues, Rita Barros-Pereira, Ricardo Falcão, Manuel Fernandes, Vítor Alves-Faria, Pedro Falcão-Reis, Fernando Rocha-Sousa, Amândio Clin Ophthalmol Original Research PURPOSE: The purpose of this study was to characterize the clinical presentation, management strategy and visual outcomes of patients diagnosed with Terson syndrome and followed in a tertiary centre in Portugal. PATIENTS AND METHODS: A single-centre retrospective study was performed, based on the survey review of the medical records of every consecutive patient diagnosed with Terson syndrome and followed from January 2018 to August 2021. The change in best-corrected visual acuity (BCVA) from baseline to the final evaluation was the primary outcome. RESULTS: Fifteen eyes from 8 patients (50% female) were included. The mean age at diagnosis was 55±7 years. The neurological event was traumatic brain injury in 37.5% (n=3) and subarachnoid haemorrhage in 62.5% of the patients (n=5). Bilateral intraocular haemorrhage occurred in 875% (n=7) of the patients. Vitreous and preretinal haemorrhages occurred each in 66.7% (n=10), intraretinal in 30% (n=3) and subretinal in 13.3% (n=2) of the eyes. In 40% of the eyes (n=6), spontaneous resolution of intraocular haemorrhage occurred, while PPV was performed in the remaining 60% (n=9). Ocular haemorrhage detection occurred 58.47 ± 40.94 days after the neurological event (range 11 to 121 days). Baseline BCVA was 1.11 ± 1.01 logMAR and improved to 0.32 ± 0.69 logMAR in the follow-up period (p=0.004). A positive correlation was found between initial and final BCVA (Spearman’s rho = 0.643, p=0.01). Baseline BCVA of eyes undergoing PPV was lower than of those conservatively managed (1.84±0.72 vs 0.20±0.28 logMAR, p<0.001). However, there were no statistically significant differences in final BCVA after surgery or observation (0.56 ± 0.90 vs 0.04 ± 0.04 logMAR, p=0.149). Longer periods between the neurological and the ophthalmological diagnosis were correlated with worse final BCVA (Spearman’s rho = 0.688, p=0.005). CONCLUSION: Terson syndrome is a potential cause of irreversible visual loss. Diagnosis delay may affect visual prognosis. PPV is indicated when intraocular haemorrhage is dense and does not resolve spontaneously or when visual acuity at presentation is low, allowing for good visual outcomes with minimal complications. Dove 2023-01-25 /pmc/articles/PMC9884450/ /pubmed/36721665 http://dx.doi.org/10.2147/OPTH.S396781 Text en © 2023 Lima-Fontes et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Lima-Fontes, Mario
Leuzinger-Dias, Mariana
Rodrigues, Rita
Barros-Pereira, Ricardo
Falcão, Manuel
Fernandes, Vítor
Alves-Faria, Pedro
Falcão-Reis, Fernando
Rocha-Sousa, Amândio
Terson Syndrome – Clinical Presentation, Management, and Visual Outcomes in a Tertiary Centre
title Terson Syndrome – Clinical Presentation, Management, and Visual Outcomes in a Tertiary Centre
title_full Terson Syndrome – Clinical Presentation, Management, and Visual Outcomes in a Tertiary Centre
title_fullStr Terson Syndrome – Clinical Presentation, Management, and Visual Outcomes in a Tertiary Centre
title_full_unstemmed Terson Syndrome – Clinical Presentation, Management, and Visual Outcomes in a Tertiary Centre
title_short Terson Syndrome – Clinical Presentation, Management, and Visual Outcomes in a Tertiary Centre
title_sort terson syndrome – clinical presentation, management, and visual outcomes in a tertiary centre
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884450/
https://www.ncbi.nlm.nih.gov/pubmed/36721665
http://dx.doi.org/10.2147/OPTH.S396781
work_keys_str_mv AT limafontesmario tersonsyndromeclinicalpresentationmanagementandvisualoutcomesinatertiarycentre
AT leuzingerdiasmariana tersonsyndromeclinicalpresentationmanagementandvisualoutcomesinatertiarycentre
AT rodriguesrita tersonsyndromeclinicalpresentationmanagementandvisualoutcomesinatertiarycentre
AT barrospereiraricardo tersonsyndromeclinicalpresentationmanagementandvisualoutcomesinatertiarycentre
AT falcaomanuel tersonsyndromeclinicalpresentationmanagementandvisualoutcomesinatertiarycentre
AT fernandesvitor tersonsyndromeclinicalpresentationmanagementandvisualoutcomesinatertiarycentre
AT alvesfariapedro tersonsyndromeclinicalpresentationmanagementandvisualoutcomesinatertiarycentre
AT falcaoreisfernando tersonsyndromeclinicalpresentationmanagementandvisualoutcomesinatertiarycentre
AT rochasousaamandio tersonsyndromeclinicalpresentationmanagementandvisualoutcomesinatertiarycentre